China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
1.870
+0.010 (0.54%)
At close: Sep 16, 2025, 4:00 PM EDT
1.810
-0.060 (-3.21%)
Pre-market: Sep 17, 2025, 7:43 AM EDT
China SXT Pharmaceuticals Market Cap
China SXT Pharmaceuticals has a market cap or net worth of $216.97 million as of September 17, 2025. Its market cap has increased by 8,946.15% in one year.
Market Cap
216.97M
Enterprise Value
199.72M
1-Year Change
8,946.15%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since January 4, 2019, China SXT Pharmaceuticals's market cap has increased from $129.31M to $216.97M, an increase of 67.79%. That is a compound annual growth rate of 8.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 216.97M | 12,184.67% |
| Dec 31, 2024 | 1.77M | -21.33% |
| Dec 29, 2023 | 2.25M | 54.15% |
| Dec 30, 2022 | 1.46M | -85.57% |
| Dec 31, 2021 | 10.10M | -48.92% |
| Dec 31, 2020 | 19.76M | -10.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |